CINECA IRIS Institutional Research Information System

ROMAGNOLO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.130
EU - Europa 2.408
AS - Asia 1.764
SA - Sud America 291
AF - Africa 42
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.044
SG - Singapore 673
IT - Italia 639
CN - Cina 589
DE - Germania 309
IE - Irlanda 282
SE - Svezia 262
BR - Brasile 250
FR - Francia 158
FI - Finlandia 157
AT - Austria 135
JP - Giappone 117
GB - Regno Unito 102
IN - India 74
ES - Italia 64
HK - Hong Kong 63
CA - Canada 62
VN - Vietnam 54
NL - Olanda 43
KR - Corea 42
UA - Ucraina 41
PL - Polonia 40
TR - Turchia 37
BE - Belgio 36
AU - Australia 31
ID - Indonesia 25
PT - Portogallo 21
CH - Svizzera 19
MX - Messico 18
GR - Grecia 17
AR - Argentina 16
RO - Romania 16
RU - Federazione Russa 15
TW - Taiwan 15
CZ - Repubblica Ceca 13
UZ - Uzbekistan 11
BD - Bangladesh 9
CO - Colombia 9
MA - Marocco 9
CL - Cile 7
IR - Iran 7
ZA - Sudafrica 7
CY - Cipro 6
EC - Ecuador 6
EG - Egitto 6
SN - Senegal 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
DK - Danimarca 5
LT - Lituania 5
PH - Filippine 5
SA - Arabia Saudita 5
SI - Slovenia 5
TN - Tunisia 5
IQ - Iraq 4
MY - Malesia 4
NZ - Nuova Zelanda 4
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
JM - Giamaica 3
TH - Thailandia 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
CM - Camerun 2
KW - Kuwait 2
MT - Malta 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
RS - Serbia 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
PY - Paraguay 1
QA - Qatar 1
SV - El Salvador 1
TL - Timor Orientale 1
Totale 8.672
Salva come PNG Salva come JPEG
Città #
Chandler 629
Santa Clara 377
Singapore 377
Dublin 280
Beijing 247
Ann Arbor 191
Ashburn 189
Torino 188
Fairfield 172
Munich 141
Houston 116
Nyköping 116
Vienna 116
Helsinki 95
Wilmington 94
Redwood City 91
Columbus 89
Woodbridge 88
Medford 87
Princeton 79
Turin 79
Villeurbanne 74
Seattle 59
Dearborn 58
Cambridge 48
Boston 43
Hong Kong 39
Jacksonville 39
Dong Ket 37
Milan 33
Boardman 30
Hangzhou 30
São Paulo 30
New York 29
Pisa 28
Brussels 27
Fremont 26
Guangzhou 24
Rome 24
Shanghai 24
Warsaw 24
Hefei 22
Jakarta 22
Los Angeles 21
Seoul 21
Düsseldorf 20
Nanjing 19
Tokyo 19
Chengdu 18
Madrid 17
Norwalk 14
Ottawa 14
Silver Spring 14
Turku 14
Dallas 13
Hebei 13
Washington 13
London 12
Toronto 12
Xian 12
Central District 11
Nuremberg 11
Amsterdam 10
Lauterbourg 10
Wuhan 10
Chicago 9
Falkenstein 9
Fort Worth 9
San Diego 9
Taipei 9
Barcelona 8
Brasília 8
Mumbai 8
Riverton 8
San Francisco 8
Aracaju 7
Belo Horizonte 7
Bologna 7
Falls Church 7
Istanbul 7
Jinan 7
Jyväskylä 7
Phoenix 7
Santiago 7
Sydney 7
Verona 7
Agliè 6
Brooklyn 6
Buenos Aires 6
Medellín 6
Nanchang 6
Xi'an 6
Bern 5
Bethesda 5
Bricherasio 5
Chongqing 5
Duncan 5
Frankfurt am Main 5
Hamburg 5
Hiroshima 5
Totale 5.167
Salva come PNG Salva come JPEG
Nome #
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 681
Levodopa-carbidopa intestinal gel infusion and weight loss in Parkinson's disease 439
Progranulin expression in brain tissue and cerebrospinal fluidlevels in multiple sclerosis 399
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 364
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation. 305
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 237
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 228
Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease 164
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment 154
What Happens When I Watch a Ballet and I Am Dyskinetic? A fMRI Case Report in Parkinson Disease. 152
Neurological comorbidity and severity of COVID-19 143
Blood pressure circadian rhythm alterations in alpha-synucleinopathies 123
Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside 111
Role of the cingulate cortex in dyskinesias-reduced-self-awareness: An fMRI study on Parkinson's disease patients 108
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 106
Cardiac organ damage in patients with Parkinson's disease and reverse dipping 106
CIDP-like neuropathies in graft versus host disease 105
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 104
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 102
Trait impulsivity and response-inhibition in Parkinson Disease. An fMRI study. 101
Advanced therapies in Parkinson's disease: Long-term retrospective study 100
Pisa syndrome in Parkinson's disease is associated with specific cognitive alterations 94
Verbal communication about drug dosage balances drug reduction in Parkinson's disease: Behavioral and electrophysiological evidences 93
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 91
Detection of orthostatic hypotension with ambulatory blood pressure monitoring in parkinson’s disease 89
Neurodegeneration and iron accumulation in deep grey matter nuclei in multiple sclerosis. 87
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson’s Disease? 86
A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion 85
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 85
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 84
Transdermal rotigotine in dihydropteridine reductase deficiency 84
Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: A long-term prospective assessment 84
Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming 84
Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response 83
Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic? 83
Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease 83
A new index to assess turning quality and postural stability in patients with Parkinson's disease 83
Autonomic dysfunction in Parkinson's disease: A prospective cohort study 82
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 80
Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria? 79
Orthostatic hypotension in Parkinson disease: Impact on health care utilization 78
Machine learning applied to ambulatory blood pressure monitoring: a new tool to diagnose autonomic failure? 76
Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data 75
COVID-19 and Parkinson's Disease: What We Know So Far? 75
Telemedicine in Neurological Disorders: Opportunities and Challenges 74
Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 74
Home monitoring of motor fluctuations in Parkinson’s disease patients 73
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease 73
COVID-19 in Parkinson's disease: Report on prevalence and outcome 72
Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease 72
Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease 72
Parkinsonism–hyperpyrexia syndrome and deep brain stimulation 71
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis 70
Differential response to pallidal deep brain stimulation among monogenic dystonias: Systematic review and meta-analysis 70
Onset of Covid-19 with impaired consciousness and ataxia: a case report 69
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study 67
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum 67
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials 66
Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit 65
Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report 65
Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease 64
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease 64
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach 63
Tuning Deep Brain Stimulation related depression by frequency modulation: a case report 63
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 63
Peripheral neuropathy as marker of severe Parkinson's disease phenotype 62
Orthostatic hypotension and REM sleep behaviour disorder: Impact on clinical outcomes in α-synucleinopathies 62
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection 62
Subcutaneous "bolus" immunoglobulin dose in CIDP: A proof-of concept study 61
Neurological comorbidities and COVID-19-related case fatality: A cohort study 61
Effect of subthalamic deep brain stimulation on posture in Parkinson's disease: A blind computerized analysis 56
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach 53
Preliminary evidence from a Line-Bisection Task for visuospatial neglect in Parkinson's disease 53
Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition 51
Prevalence and burden of dysautonomia in advanced Parkinson's disease 50
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients 47
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review 47
Functional neurological disorders in Parkinson disease 47
Levodopa-Induced Neuropathy: A Systematic Review 44
Subthalamic deep brain stimulation and trunk posture in Parkinson's disease 44
Differential impact of individual autonomic domains on clinical outcomes in Parkinson's disease 44
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease 43
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson’s disease patient with Parkin gene mutation: a case report 42
How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease 34
Multiple sclerosis relapses: a multivariable analysis of residual disability determinants 32
Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations 31
Reply to: "Autonomic dysfunction in Parkinson's disease: The hidden game changer?" 30
Hypotensive episodes at 24-h ambulatory blood pressure monitoring predict adverse outcomes in Parkinson’s disease 28
Incidence and predictors of postural abnormalities in Parkinson's disease: a PPMI cohort study 25
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 24
Effects of Continuous Dopaminergic Stimulation on Parkinson's Disease Gait: A Longitudinal Prospective Study with Levodopa Intestinal Gel Infusion 24
NoMoFa as a new tool to evaluate the impact of deep brain stimulation on non-motor fluctuations: A new perspective 21
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease 20
Neurological symptoms in adults with Gaucher disease: a systematic review 19
Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson's disease 8
Totale 8.917
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.902
article - articoli 0
book - libri 0
conference - conferenze 576
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.478
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021820 61 121 82 47 66 55 47 59 66 65 54 97
2021/20221.056 56 35 47 111 61 49 51 50 47 85 262 202
2022/20231.590 166 173 51 173 154 391 90 89 164 35 70 34
2023/2024756 111 129 42 28 76 96 26 46 4 57 41 100
2024/20252.319 31 105 62 194 585 206 136 163 240 126 176 295
2025/202684 84 0 0 0 0 0 0 0 0 0 0 0
Totale 8.917